December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

84.33 +3.54 (+4.38%)
Streaming Delayed Price Updated: 11:49 AM EDT, Jun 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow
From DNAnexus, Inc.
Via Business Wire
News headline image
7 Best Biotech Stocks to Buy in July 2022 ↗
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict. 
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. 
Via Benzinga
News headline image
Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
From Twist Bioscience Corporation
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
On Tuesday, 951 companies hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
During Monday's trading, 1214 companies set new 52-week lows. 
Via Benzinga
News headline image
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies ↗
 
Via Benzinga
News headline image
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Reports Second Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience's Earnings: A Preview ↗
Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Twist... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches High Throughput Antibody Production Platform
From Twist Bioscience Corporation
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 236 companies hit new 52-week lows. 
Via Benzinga
News headline image
Twist Bioscience to Become Voting Member of Storage Networking Industry Association
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Promotions and Changes to Executive Leadership Team
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2022 Second Quarter Financial Results on Thursday, May 5, 2022
From Twist Bioscience Corporation
Via Business Wire
News headline image
Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here’s Why. ↗
Baillie Gifford recently disclosed that it purchased 48.8 million shares of DNA stock on March 31. The firm has a $180 billion portfolio. 
Via InvestorPlace
News headline image
Twist Bioscience Inks Antibody Discovery Pact With MediSix Therapeutics ↗
Twist Bioscience Corporation (NASDAQ: TWST) and MediSix Therapeutics have collaborated to discover novel antibodies  
Via Benzinga
News headline image
Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
From Twist Bioscience Corporation
Via Business Wire
News headline image
DNA Data Storage Alliance Welcomes 50th Member
From DNA Data Storage Alliance
Via Business Wire
News headline image
Know The 2 Healthcare Companies Cathie Wood's Ark Invest Bought On Friday ↗
Cathie Wood's Ark Invest may have had a disappointing 2021, but the fund's purchases/liquidations are always watched keenly by investors. On Friday, ETFs managed by... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.